Skip to main content
OpenTrials

Clinical trial condition

Langerhans Cell Histiocytosis

Explore clinical trials studying Langerhans Cell Histiocytosis. Study availability and eligibility vary by location and protocol.

17 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Langerhans Cell Histiocytosis trial results

Recruiting

Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

NCT02670707

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • Stanford Children's Hospital, Lucile Packard Children's Hospital Palo Alto, California, United States
  • Rady Children's Hospital - San Diego San Diego, California, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
View Trial Details
Recruiting

To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH

NCT05997602

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +6 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Children's Hospital Affiliated to the Capital Institute of Pediatrics Beijing, Beijing Municipality, China
  • Children's Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Sun Yat-Sen Memorial Hpsipital,Sun Yat-Sen Unniversity Guangzhou, Guangdong, China
View Trial Details
Completed

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

NCT03220035

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma, +67 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 116 locations
View Trial Details
Completed

A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

NCT01395004

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Staten Island University Hospital Staten Island, New York, United States
View Trial Details

Related conditions